These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25827475)

  • 1. Dengue vaccines for travelers: has the time come?
    Wilder-Smith A
    J Travel Med; 2015; 22(3):200-2. PubMed ID: 25827475
    [No Abstract]   [Full Text] [Related]  

  • 2. Exploring the role of a recently licensed dengue vaccine in Australian travellers.
    Thevarajan I; Torresi J; Simmons C
    Med J Aust; 2020 Feb; 212(3):102-103.e1. PubMed ID: 31909484
    [No Abstract]   [Full Text] [Related]  

  • 3. New chapter unfolding in the fight against dengue with an unwritten ending.
    Thiry G; Hombach J; Constenla D; Carvalho A; Durbin A
    Trans R Soc Trop Med Hyg; 2014 Oct; 108(10):597-8. PubMed ID: 25217182
    [No Abstract]   [Full Text] [Related]  

  • 4. Should travellers be offered vaccination against the dengue virus?
    Javelle E; Al Balushi A; Jespersen S; Al Abri S; Gautret P; Petersen E
    Travel Med Infect Dis; 2019; 27():2-4. PubMed ID: 30267771
    [No Abstract]   [Full Text] [Related]  

  • 5. Serostatus-dependent performance of the first licensed dengue vaccine: implications for travellers.
    Wilder-Smith A
    J Travel Med; 2018 Aug; 25(1):. PubMed ID: 30016457
    [No Abstract]   [Full Text] [Related]  

  • 6. The first licensed dengue vaccine: an important tool for integrated preventive strategies against dengue virus infection.
    Pitisuttithum P; Bouckenooghe A
    Expert Rev Vaccines; 2016 Jul; 15(7):795-8. PubMed ID: 27171845
    [No Abstract]   [Full Text] [Related]  

  • 7. Defeating dengue: a challenge for a vaccine.
    Nat Med; 2012 Nov; 18(11):1622-3. PubMed ID: 23135514
    [No Abstract]   [Full Text] [Related]  

  • 8. The human dengue challenge experience at the Walter Reed Army Institute of Research.
    Lyons AG
    J Infect Dis; 2014 Jun; 209 Suppl 2():S49-55. PubMed ID: 24872396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outlook for a dengue vaccine.
    Norrby R
    Clin Microbiol Infect; 2014 May; 20 Suppl 5():92-4. PubMed ID: 24438016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dengue vaccines approach the finish line.
    Edelman R
    Clin Infect Dis; 2007 Jul; 45 Suppl 1():S56-60. PubMed ID: 17582571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against dengue virus by non-replicating and live attenuated vaccines used together in a prime boost vaccination strategy.
    Simmons M; Burgess T; Lynch J; Putnak R
    Virology; 2010 Jan; 396(2):280-8. PubMed ID: 19913867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptability of hypothetical dengue vaccines among travelers.
    Benoit CM; MacLeod WB; Hamer DH; Sanchez-Vegas C; Chen LH; Wilson ME; Karchmer AW; Yanni E; Hochberg NS; Ooi WW; Kogelman L; Barnett ED
    J Travel Med; 2013; 20(6):346-51. PubMed ID: 24165380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DENGUE VACCINES.
    Thisyakorn U; Thisyakorn C
    Southeast Asian J Trop Med Public Health; 2015; 46 Suppl 1():138-45. PubMed ID: 26506740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SAGE committee advice on dengue vaccine.
    Pang T
    Lancet Infect Dis; 2016 Aug; 16(8):880-2. PubMed ID: 27477966
    [No Abstract]   [Full Text] [Related]  

  • 15. From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine.
    Guy B; Barrere B; Malinowski C; Saville M; Teyssou R; Lang J
    Vaccine; 2011 Sep; 29(42):7229-41. PubMed ID: 21745521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sanofi's dengue vaccine first to complete phase 3.
    Sinha G
    Nat Biotechnol; 2014 Jul; 32(7):605-6. PubMed ID: 25004214
    [No Abstract]   [Full Text] [Related]  

  • 17. Tropical diseases. Hunt for dengue vaccine heats up as the disease burden grows.
    Normile D
    Science; 2007 Sep; 317(5844):1494-5. PubMed ID: 17872423
    [No Abstract]   [Full Text] [Related]  

  • 18. Dengue vaccines for travelers.
    Wilder-Smith A; Deen JL
    Expert Rev Vaccines; 2008 Jul; 7(5):569-78. PubMed ID: 18564012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial.
    Sabchareon A; Wallace D; Sirivichayakul C; Limkittikul K; Chanthavanich P; Suvannadabba S; Jiwariyavej V; Dulyachai W; Pengsaa K; Wartel TA; Moureau A; Saville M; Bouckenooghe A; Viviani S; Tornieporth NG; Lang J
    Lancet; 2012 Nov; 380(9853):1559-67. PubMed ID: 22975340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dengue vaccine prospects: a step forward.
    Guy B; Almond J; Lang J
    Lancet; 2011 Jan; 377(9763):381-2. PubMed ID: 21277439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.